Review explores PCSK9 inhibitors for familial hypercholesterolemia

Familial hypercholesterolemia is a condition where your body cannot remove enough bad cholesterol from your blood. This can lead to heart disease if left untreated. A recent narrative review examines a specific class of drugs called PCSK9 inhibitors, such as evolocumab. These medications help lower cholesterol levels in people who need extra help beyond standard treatments. The review explains how these drugs target a protein called PCSK9 to improve heart health. It highlights that these options exist for those who struggle with high cholesterol despite other efforts. The text notes that this information comes from a review rather than a new clinical trial. Because it is a review, it summarizes existing knowledge instead of testing new ideas on patients. Readers should understand that this source does not report new safety data or specific trial results. The focus remains on explaining the role of these drugs in managing a serious condition. It is important to remember that medical decisions should always involve a doctor who knows your full history.